- Home
- RNTX vs FSEA Comparison
RNTX vs FSEA Comparison
Compare RNTX & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- FSEA
- Stock Information
- Founded
- RNTX 2001
- FSEA 1890
- Country
- RNTX United States
- FSEA United States
- Employees
- RNTX N/A
- FSEA N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- RNTX Health Care
- FSEA Finance
- Exchange
- RNTX Nasdaq
- FSEA Nasdaq
- Market Cap
- RNTX 44.2M
- FSEA 51.2M
- IPO Year
- RNTX N/A
- FSEA N/A
- Fundamental
- Price
- RNTX $1.74
- FSEA $11.55
- Analyst Decision
- RNTX
- FSEA
- Analyst Count
- RNTX 0
- FSEA 0
- Target Price
- RNTX N/A
- FSEA N/A
- AVG Volume (30 Days)
- RNTX 25.1K
- FSEA 6.8K
- Earning Date
- RNTX 05-14-2025
- FSEA 05-09-2025
- Dividend Yield
- RNTX N/A
- FSEA N/A
- EPS Growth
- RNTX N/A
- FSEA N/A
- EPS
- RNTX N/A
- FSEA N/A
- Revenue
- RNTX N/A
- FSEA $15,874,000.00
- Revenue This Year
- RNTX N/A
- FSEA N/A
- Revenue Next Year
- RNTX N/A
- FSEA N/A
- P/E Ratio
- RNTX N/A
- FSEA N/A
- Revenue Growth
- RNTX N/A
- FSEA 70.41
- 52 Week Low
- RNTX $1.61
- FSEA $8.25
- 52 Week High
- RNTX $7.42
- FSEA $11.69
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- FSEA 68.73
- Support Level
- RNTX N/A
- FSEA $11.32
- Resistance Level
- RNTX N/A
- FSEA $11.69
- Average True Range (ATR)
- RNTX 0.00
- FSEA 0.17
- MACD
- RNTX 0.00
- FSEA 0.01
- Stochastic Oscillator
- RNTX 0.00
- FSEA 79.71
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.